Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
bullish
Health Care
Presentation for Webinar: China Healthcare - Outlook and Opportunities in 2022
Thematic (Sector/Industry)
396 Views
17 Feb 2022 00:29
We review the important events since 2021H1 and keep bullish on China healthcare outlook.We also analyzed investment logic and opportunities in 2022 covering medical device, TCM, biotech, CXO sectors.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 8-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
Philippines
Event-Driven
Sell / Short Ideas
India
Asia Event-Driven
South Korea
Credit
Japan
Trending Insights
More »
Gold Miners ETF (GDX US): Big Outperformance Driven by Benchmark Change; Valuation Gap Opens Up
Quiddity Leaderboard STAR 50/100 Sep25: Final Expectations; New Pair Trades
Sun Corp (6736) - CLBT Has Round-Tripped, But Now Better ParentCo and a Buyback so Set-Up Is Better
China A50 ETFs Rebalance Preview: Three Changes in September
HKBN (1310 HK): China Mobile Satisfies the Precondition
Top Unpaywalled Insights
More »
Tradesmen's Collective: Fixing the Trades with Tech, Transparency & Boots-on-the-Ground
VEON 2Q25: Solid Digital Non-Telco Products Uplift, Kyivstar Listing in Focus
[IO Technicals 2025/32] Bullish Momentum Builds
Grab Holdings (GRAB US) - Harvesting Sequentially
Micro-Mechanics (Holdings) Limited - Next Generation Supplier of the Semicon Industry
Discussions
(Paid Plans Only)
Insight Stream
China Shineway Pharmaceutical (2877.HK) - Uncertainties Cloud the Outlook
22 Feb 2022
Modern Dental Group (3600.HK) - More Suitable for Short Term Trading than Long Term Holding
21 Feb 2022
China Healthcare Weekly (Feb.18)-VBP Expansion, China Drug Pricing System,FDA Approval,Junshi/Legend
20 Feb 2022
Presentation for Webinar: China Healthcare - Outlook and Opportunities in 2022
17 Feb 2022
The Insecure Rebound in Healthcare Sector and the Future Direction of Stock Price (2022)
17 Jan 2022
The CXO/Biotech Plunge and the Afterwards Investment Logic (2022)
20 Dec 2021
2022 High Conviction (China Healthcare) - Seek the Relative Certainties Out of the Uncertainties
25 Nov 2021
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.1
x